Invasive Group B Streptococcal Disease in Non-pregnant Adults

[1]  Natalie Masuoka.  Defining the Group , 2008 .

[2]  M. Cieslewicz,et al.  A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. , 2007, Journal of medical microbiology.

[3]  A. Norrby-Teglund,et al.  Streptococcus agalactiae in relapsing cellulitis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  R. Barnes,et al.  Group B streptococcus toxic shock-like syndrome in a healthy woman: a case report. , 2007, The Journal of reproductive medicine.

[5]  Ronald N. Jones,et al.  Oral β-lactams applied to uncomplicated infections of skin and skin structures , 2007 .

[6]  N. Raja,et al.  Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. , 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[7]  Ronald N. Jones,et al.  Oral beta-lactams applied to uncomplicated infections of skin and skin structures. , 2007, Diagnostic microbiology and infectious disease.

[8]  M. Brady,et al.  Streptococcal septic shock after inguinal lymphadenectomy. , 2006, Surgical infections.

[9]  N. Cox.  Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow‐up , 2006, The British journal of dermatology.

[10]  M. Falagas,et al.  Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[11]  N. L. van der Mee-Marquet,et al.  Severe relapsing erysipelas associated with chronic Streptococcus agalactiae vaginal colonization. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Wei-Chih Liao,et al.  Clinical characteristics of group B streptococcus bacteremia in non-pregnant adults. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[13]  A. Hirano,et al.  Lower extremity reconstruction after necrotising fasciitis and necrotic skin lesions using a porcine-derived skin substitute. , 2006, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[14]  H. Leu,et al.  Group B streptococcal bacteremia in non-pregnant adults. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[15]  B. Tan,et al.  Abdominal Wall Necrotizing Fasciitis: It Is Still “Meleney’s Minefield” , 2006, Plastic and reconstructive surgery.

[16]  Haruo Watanabe,et al.  Surveillance of group B streptococcal toxic shock-like syndrome in nonpregnant adults and characterization of the strains in Japan. , 2006, Japanese journal of infectious diseases.

[17]  B. Spellerberg,et al.  Epidemiology of Streptococcus agalactiae colonization in Germany. , 2006, International journal of medical microbiology : IJMM.

[18]  A. Norrby-Teglund,et al.  Viable Group A Streptococci in Macrophages during Acute Soft Tissue Infection , 2006, PLoS medicine.

[19]  K. Soares-Weiser,et al.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. , 2006, The Cochrane database of systematic reviews.

[20]  L. Dipersio,et al.  High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. , 2006, Diagnostic microbiology and infectious disease.

[21]  Patchen Dellinger,et al.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  C. Baker,et al.  Group B streptococcal infections in elderly adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. François,et al.  Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. , 2005, The Journal of infectious diseases.

[24]  Hyo Youl Kim,et al.  Correlation of Serotypes and Genotypes of Macrolide-Resistant Streptococcus agalactiae , 2005, Yonsei medical journal.

[25]  B. Spratt,et al.  Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching , 2005, Journal of Clinical Microbiology.

[26]  H. Konradsen,et al.  Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  W. Ko,et al.  Group B streptococcal soft tissue infections in non-pregnant adults. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  J. Wagner,et al.  Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  R. Berner,et al.  Heterogeneity of Genotype-Phenotype Correlation among Macrolide-Resistant Streptococcus agalactiae Isolates , 2005, Antimicrobial Agents and Chemotherapy.

[30]  J. Bohnen,et al.  Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach , 2005, Scandinavian journal of infectious diseases.

[31]  D. Kasper,et al.  Regulation of Virulence by a Two-Component System in Group B Streptococcus , 2005, Journal of bacteriology.

[32]  C. Baker,et al.  Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  G. Lindahl,et al.  Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.

[34]  C. Jorup-Rönström,et al.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas , 1984, Infection.

[35]  C. Jorup-Rönström,et al.  Skin concentrations of phenoxymethylpenicillin in patients with erysipelas , 2005, Infection.

[36]  V. Nizet,et al.  Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Spellerberg,et al.  Surface proteins of Streptococcus agalactiae and horizontal gene transfer. , 2004, International journal of medical microbiology : IJMM.

[38]  C. Baker,et al.  Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. , 2004, The Journal of infectious diseases.

[39]  B. Gillespie,et al.  Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  M. Bergeron,et al.  Laboratory detection of group B Streptococcus for prevention of perinatal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[41]  K. Tan,et al.  Group B Streptococcus necrotizing fasciitis: an emerging disease? , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[42]  S. Schnall,et al.  Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. , 2004, The Journal of bone and joint surgery. American volume.

[43]  W. James,et al.  Group B streptococcal toxic shock-like syndrome. , 2004, Archives of dermatology.

[44]  W. Keitel,et al.  Healthy Elderly People Lack Neutrophil‐Mediated Functional Activity to Type V Group B Streptococcus , 2004, Journal of the American Geriatrics Society.

[45]  T. Hasegawa,et al.  Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome , 2004, Journal of Clinical Microbiology.

[46]  K. Tan.  Streptococcus necrotizing fasciitis : an emerging disease ? , 2004 .

[47]  F. Alcaide,et al.  Group B Streptococcal Disease in Nonpregnant Adults: Incidence, Clinical Characteristics, and Outcome , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[48]  M. Wallace,et al.  Group B Streptococcal Necrotizing Fasciitis and Toxic Shock-Like Syndrome: A Case Report and Review of the Literature , 2003, Scandinavian journal of infectious diseases.

[49]  M. Palmer,et al.  Characterization of Streptococcus agalactiae CAMP Factor as a Pore-forming Toxin* , 2003, Journal of Biological Chemistry.

[50]  P. Leaverton,et al.  Invasive Group A Streptococcal Infections in Florida , 2003, Southern medical journal.

[51]  H. Slotved,et al.  Emergence of Invasive Serotype VIII Group B Streptococcal Infections in Denmark , 2003, Journal of Clinical Microbiology.

[52]  A. Norrby-Teglund,et al.  Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  R. Berner,et al.  A Serotype V Clone Is Predominant among Erythromycin-Resistant Streptococcus agalactiae Isolates in a Southwestern Region of Germany , 2003, Journal of Clinical Microbiology.

[54]  B. Foxman,et al.  Correlates of Antibiotic‐Resistant Group B Streptococcus Isolated From Pregnant Women , 2003, Obstetrics and gynecology.

[55]  V. Nizet.  Streptococcal β-hemolysins: genetics and role in disease pathogenesis , 2002 .

[56]  Malak Kotb,et al.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections , 2002, Nature Medicine.

[57]  B. Gillespie,et al.  Determinants of Co-Colonization with Group B Streptococcus Among Heterosexual College Couples , 2002, Epidemiology.

[58]  L. Meyn,et al.  Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. , 2002, American journal of epidemiology.

[59]  Q. Cheng,et al.  The Group B Streptococcal C5a Peptidase Is Both a Specific Protease and an Invasin , 2002, Infection and Immunity.

[60]  B. Spellerberg,et al.  rgf Encodes a Novel Two-Component Signal Transduction System of Streptococcus agalactiae , 2002, Infection and Immunity.

[61]  V. Nizet,et al.  Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. , 2002, The Journal of infectious diseases.

[62]  Mamta Sharma,et al.  Clinical Characteristics of Necrotizing Fasciitis Caused by Group G Streptococcus: Case Report and Review of the Literature , 2002, Scandinavian journal of infectious diseases.

[63]  V. Nizet.  Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. , 2002, Trends in microbiology.

[64]  P. K. Lieu,et al.  Epidemiology of beta-haemolytic group G streptococcal bacteraemia in Singapore (1996 to 1998). , 2002, Annals of the Academy of Medicine, Singapore.

[65]  Patrick C Y Woo,et al.  Streptococcus agalactiae (Lancefield Group B) Bacteraemia in Nonpregnant Adults , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[66]  Panupong Larppanichpoonphol.  Group B Streptococcal Bacteremia in Nonpregnant Adults at a Community Teaching Hospital , 2001, Southern medical journal.

[67]  D. Murdoch,et al.  Antimicrobial Susceptibilities of Group B Streptococci Isolated from Patients with Invasive Disease: 10-Year Perspective , 2001, Antimicrobial Agents and Chemotherapy.

[68]  F. Fiedler,et al.  Regulation of d-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus agalactiae Involves a Novel Two-Component Regulatory System , 2001, Journal of bacteriology.

[69]  K. Soares-Weiser,et al.  Beta lactam monotherapy versus beta lactam‐aminoglycoside combination therapy for treating sepsis , 2001 .

[70]  L. Schouls,et al.  Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. , 2001, International journal of antimicrobial agents.

[71]  J. Woo,et al.  Group B Streptococcal Bacteremia in Nonpregnant Adults with Hepatic Disease in Korea , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[72]  M. Farley.  Group B streptococcal disease in nonpregnant adults. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  M. Baptista,et al.  Contribution of Mn-Cofactored Superoxide Dismutase (SodA) to the Virulence of Streptococcus agalactiae , 2001, Infection and Immunity.

[74]  C. Gemmell.  Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison. , 2001, The Journal of antimicrobial chemotherapy.

[75]  M. Edwards,et al.  Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. , 2001, Molecular genetics and metabolism.

[76]  A. Schuchat,et al.  Invasive group B streptococcal disease in Maryland nursing home residents. , 2001, The Journal of infectious diseases.

[77]  G. Lindahl,et al.  Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89* , 2001, The Journal of Biological Chemistry.

[78]  B. Holmström,et al.  Necrotizing fasciitis and toxic shock-like syndrome caused by group B streptococcus. , 2000, Southern medical journal.

[79]  D. Kasper,et al.  Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.

[80]  Tallman,et al.  Prevalence and co-colonization with group b streptococcus (Gbs) Among heterosexual college couples. , 2000, Annals of epidemiology.

[81]  K. Fettucciari,et al.  Group B Streptococcus Induces Apoptosis in Macrophages1 , 2000, The Journal of Immunology.

[82]  W. Tang,et al.  Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  V. Nizet,et al.  Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression. , 2000, The Journal of infectious diseases.

[84]  J. Troendle,et al.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  G. Tyrrell,et al.  Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. , 2000, The Journal of infectious diseases.

[86]  C. Baker,et al.  A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[88]  D. Raveh,et al.  Cost-effectiveness of blood cultures for adult patients with cellulitis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  P. Ferrieri,et al.  Changing Epidemiology of Group B Streptococcal Colonization , 1999, Pediatrics.

[90]  R. Kaul,et al.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[91]  D. Kasper,et al.  Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. , 1999, The Journal of infectious diseases.

[92]  R. Kaul,et al.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  D. Kasper,et al.  Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.

[94]  C. Rubens,et al.  Characterization of Group B Streptococcal Invasion of Human Chorion and Amnion Epithelial Cells In Vitro , 1998, Infection and Immunity.

[95]  M. Miller,et al.  Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. , 1998, Archives of internal medicine.

[96]  J. Lemeland,et al.  Group B streptococcal bacteraemia in the elderly. , 1998, Journal of medical microbiology.

[97]  C. Baker,et al.  Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[98]  D. Stevens,et al.  In Vitro Antimicrobial Effects of Various Combinations of Penicillin and Clindamycin against Four Strains of Streptococcus pyogenes , 1998, Antimicrobial Agents and Chemotherapy.

[99]  A. Schuchat,et al.  Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.

[100]  J. Miller,et al.  In vivo and ex vivo regulation of bacterial virulence gene expression. , 1998, Current opinion in microbiology.

[101]  Modesti,et al.  Group B streptococci persist inside macrophages , 1998, Immunology.

[102]  V. Nizet,et al.  INVASION OF BRAIN MICROVASCULAR ENDOTHELIAL CELLS BY GROUP B STREPTOCOCCI• 1332 , 1997, Pediatric Research.

[103]  T. Peláez,et al.  Group B streptococcus bacteremia in nonpregnant adults. , 1997, Archives of internal medicine.

[104]  M. Valtonen,et al.  A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. , 1997, Scandinavian journal of infectious diseases.

[105]  E. Kaplan,et al.  Streptococcal Toxic Shock Syndrome (STSS) , 1997 .

[106]  D. Kasper,et al.  Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.

[107]  C. Jorup-Rönström,et al.  Erysipelas: clinical and bacteriologic spectrum and serological aspects. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  R. Gibson,et al.  Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells , 1996, Infection and immunity.

[109]  J. Coligan,et al.  Characterization of PepB, a group B streptococcal oligopeptidase , 1996, Infection and immunity.

[110]  D. Kasper,et al.  Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[111]  W. Dunagan,et al.  Group B Streptococcal Bacteremia in Adults , 1996 .

[112]  A. Schuchat,et al.  Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.

[113]  A. Schuchat,et al.  Risk Factors for Group B Streptococcal Disease in Adults , 1995, Annals of Internal Medicine.

[114]  L. Harrison,et al.  Relapsing Invasive Group B Streptococcal Infection in Adults , 1995, Annals of Internal Medicine.

[115]  J. Colford,et al.  Group B Streptococcal Bacteremia in Adults Five Years' Experience and a Review of the Literature , 1995, Medicine.

[116]  J. Picazo,et al.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci , 1994, Antimicrobial Agents and Chemotherapy.

[117]  C. Rubens,et al.  Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components , 1994, Infection and immunity.

[118]  D. Bessen,et al.  Allelic polymorphism of emm loci provides evidence for horizontal gene spread in group A streptococci. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[119]  P. Schlievert,et al.  Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  A. Schuchat,et al.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.

[121]  O. Jonasson,et al.  Streptococcal toxic shock-like syndrome. The importance of surgical intervention. , 1993, Annals of surgery.

[122]  J. P. Davis,et al.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. , 1993, JAMA.

[123]  L. Baddour,et al.  Group B streptococcal infection of a pacemaker wire following sigmoidoscopy. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[124]  E. Chi,et al.  Respiratory epithelial cell invasion by group B streptococci , 1992, Infection and immunity.

[125]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[126]  D. Kasper,et al.  Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci , 1992, Infection and immunity.

[127]  C. Kauffman,et al.  Group B streptococcal prosthetic joint infection following sigmoidoscopy. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[128]  A. Schuchat,et al.  Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. , 1992, JAMA.

[129]  G. Lindahl,et al.  Characterization of an IgA receptor from group B streptococci: specificity for serum IgA , 1990, European journal of immunology.

[130]  A. Buu-Hoï,et al.  High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B) , 1990, Antimicrobial Agents and Chemotherapy.

[131]  D. Kasper,et al.  Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Alouf,et al.  [Streptococcal toxic shock syndrome]. , 1989, Presse medicale.

[133]  V. Winn,et al.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. , 1988, The Journal of infectious diseases.

[134]  M. Dinubile,et al.  Necrotizing fasciitis in adults due to group B streptococcus. Report of a case and review of the literature. , 1988, Archives of internal medicine.

[135]  S. Opal,et al.  Group B streptococcal sepsis in adults and infants. Contrasts and comparisons. , 1988, Archives of internal medicine.

[136]  V. Valtonen,et al.  Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study. , 1988, Scandinavian journal of infectious diseases.

[137]  R. Arbeit,et al.  Group B streptococcal bacteremia in men. , 1986, Reviews of infectious diseases.

[138]  D. Kasper,et al.  The role of complement and antibody in opsonophagocytosis of type II group B streptococci. , 1986, The Journal of infectious diseases.

[139]  P. Gallagher,et al.  Group B streptococcal bacteremia in a community teaching hospital. , 1985, The American journal of medicine.

[140]  D. Kasper,et al.  Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.

[141]  P. Munday,et al.  Group B streptococci--gastrointestinal organisms? , 1981, Journal of clinical pathology.

[142]  R. Facklam,et al.  Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci , 1981, Antimicrobial Agents and Chemotherapy.

[143]  R. Klein,et al.  Recurrent erysipelas caused by group B streptococcus organisms. , 1980, Archives of dermatology.

[144]  E. Wolinsky,et al.  GROUP B STREPTOCOCCUS (S. AGALACTIAE) BACTEREMIA IN ADULTS: ANALYSIS OF 32 CASES AND REVIEW OF THE LITERATURE , 1977, Medicine.

[145]  A. Chow,et al.  Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. , 1976, The American journal of medicine.